LL-37

동의어: LL-37, CAP-18, Cathelicidin LL-37, Human Cathelicidin Antimicrobial Peptide, hCAP18, LL37, FALL-39, Cationic Antimicrobial Protein 18

LL-37 is a synthetic 37-amino-acid host defense peptide derived from the human cathelicidin precursor hCAP18. We supply it as a sterile-filtered lyophilized powder, typically ≥98% pure by HPLC, for research and formulation development.

Buyers source LL-37 for antimicrobial and immunomodulatory studies, often as a reference standard or as an active in topical and injectable prototypes. It ships from stock with full documentation and is available in gram to multi-gram quantities.

Applications & Formulation Use

Formulators use LL-37 in antimicrobial gel and cream prototypes, wound-care dressings, and in vitro assays for biofilm disruption. It also appears in cell-culture media supplements and in studies on innate immune response. Because it is a cationic peptide, it interacts with anionic excipients and surfaces; formulation work should account for this compatibility.

Packaging & Handling

• 포장: Supplied in amber glass vials or as bulk powder in sealed containers, purged with inert gas.
• 저장: Store at -20°C, protected from light and moisture.
• Handling: Equilibrate to room temperature before opening to prevent condensation; use immediately after reconstitution.

Bulk Supply & Ordering

• 최소 주문 수량(MOQ): 1 g
• 리드 타임: 3-5 business days (stock items)
• 문서: COA, MSDS, TDS

Contact & Ordering Information

• Company: LyvBio Co., Ltd.
• Address: Room 5-0203, Courtyard 205, Lianhu District, Xi’an, Shaanxi, China
• Email: info@lyvbio.com
• Phone/WA: +86-182-9185-7498

send us your specification for a quotation.